Showing 1 - 20 results of 30 for search 'McInnes, IB', query time: 0.38s
Refine Results
-
1
-
2
Clinical applications of machine learning algorithms: beyond the black box. by Watson, DS, Krutzinna, J, Bruce, IN, Griffiths, CE, McInnes, IB, Barnes, MR, Floridi, L
Published 2019Journal article -
3
-
4
-
5
Patient and researcher perspectives on facilitating patient and public involvement in rheumatology research by Pollock, J, Raza, K, Pratt, AG, Hanson, H, Siebert, S, Filer, A, Isaacs, JD, Buckley, CD, McInnes, IB, Falahee, M
Published 2016Journal article -
6
Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase... by Coates, LC, Rahman, P, Mease, PJ, Shawi, M, Rampakakis, E, Kollmeier, AP, Xu, XL, Chakravarty, SD, McInnes, IB, Tam, L-S
Published 2024Journal article -
7
-
8
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phas... by Coates, L, Gossec, L, Theander, E, Bergmans, P, Neuhold, M, Karyekar, CS, Shawi, M, Noel, W, Schett, G, McInnes, IB
Published 2021Journal article -
9
-
10
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis by Pournara, E, Kormaksson, M, Nash, P, Ritchlin, CT, Kirkham, BW, Ligozio, G, Pricop, L, Ogdie, A, Coates, LC, Schett, G, McInnes, IB
Published 2021Journal article -
11
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in t... by Conrad, N, Misra, S, Verbakel, JY, Verbeke, G, Molenberghs, G, Taylor, PN, Mason, J, Sattar, N, McMurray, JJV, McInnes, IB, Khunti, K, Cambridge, G
Published 2023Journal article -
12
The impact of the presence of autoantibodies against citrullinated, carbamylated and acetylated peptides on radiographic progression in patients with new onset rheumatoid arthritis... by Nijjar, JS, Morton, FR, Bang, H, van der Heijde, D, Gilmour, A, Paterson, C, McInnes, IB, Raza, K, Buckley, C, Scottish Early Rheumatoid Arthritis Inception Cohort Investigators
Published 2021Journal article -
13
Safety of guselkumab with and without prior TNF-α inhibitor treatment: pooled results across four studies in patients with psoriatic arthritis by Rahman, P, Boehncke, W-H, Mease, PJ, Gottlieb, AB, McInnes, IB, Shawi, M, Wang, Y, Sheng, S, Kollmeier, AP, Theander, E, Yu, J, Leibowitz, E, Marrache, AM, Coates, LC
Published 2023Journal article -
14
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase 3, randomised, placebo controlled, active... by Ritchlin, CT, Coates, LC, McInnes, IB, Mease, PJ, Merola, JF, Tanaka, Y, Asahina, A, Gossec, L, Gottlieb, AB, Warren, RB, Ink, B, Bajracharya, R, Shende, V, Coarse, J, Landewé, R
Published 2023Journal article -
15
Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies by Taylor, PC, Kremer, J, Emery, P, Zuckerman, S, Ruotolo, G, Zhong, J, Chen, L, Witt, S, Saifan, C, Kurzawa, M, Otvos, JD, Connelly, MA, Macias, W, Schlichting, DE, Rooney, T, de Bono, S, McInnes, IB
Published 2018Journal article -
16
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL) by McInnes, IB, Asahina, A, Coates, LC, Landewé, R, Merola, JF, Ritchlin, CT, Tanaka, Y, Gossec, L, Gottlieb, AB, Warren, RB, Ink, B, Assudani, D, Bajracharya, R, Shende, V, Coarse, J, Mease, PJ
Published 2023Journal article -
17
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III... by Coates, LC, Landewé, R, McInnes, IB, Mease, PJ, Ritchlin, CT, Tanaka, Y, Asahina, A, Behrens, F, Gladman, DD, Gosse, L, Orbai, A-M, Gottlieb, AB, Warren, RB, Ink, B, Bajracharya, R, Shende, V, Coarse, J, Merola, JF
Published 2024Journal article -
18
Bimekizumab in patients with active psoriatic arthritis and prior inadequate response or intolerance to tumour necrosis factor inhibitors: a randomised, double-blind, placebo-contr... by Merola, JF, Landewé, R, McInnes, IB, Mease, PJ, Ritchlin, CT, Tanaka, Y, Asahina, A, Behrens, F, Gladman, DD, Gossec, L, Gottlieb, AB, Thaçi, D, Warren, RB, Ink, B, Assudani, D, Bajracharya, R, Shende, V, Coarse, J, Coates, LC
Published 2022Journal article -
19
Anti–GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3) by Taylor, PC, Weinblatt, M, McInnes, IB, Atsumi, T, Strand, V, Takeuchi, T, Bracher, M, Brooks, D, Davies, J, Goode, C, Gupta, A, Mukherjee, S, O’Shea, C, Saurigny, D, Schifano, L, Shelton, C, Smith, JE, Wang, M, Wang, R, Watts, S, Fleischmann, R
Published 2023Journal article -
20
Patient reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal-forceps and arthroscopic-guided... by Just, SA, Humby, F, Lindegaard, H, De Bellefon, LM, Durez, P, Vieira-Sousa, E, Teixeira, R, Stoenoiu, M, Werlinrud, J, Rosmark, S, Larsen, PV, Pratt, A, Choy, E, Gendi, N, Buch, MH, Edwards, CJ, Taylor, PC, McInnes, IB, Fonseca, JE, Pitzalis, C, Filer, A
Published 2018Journal article